Cargando…
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD(+)-Lowering Agents
Cancer cells fuel growth and energy demands by increasing their NAD(+) biosynthesis dependency, which therefore represents an exploitable vulnerability for anti-cancer strategies. CD38 is a NAD(+)-degrading enzyme that has become crucial for anti-MM therapies since anti-CD38 monoclonal antibodies re...
Autores principales: | Becherini, Pamela, Soncini, Debora, Ravera, Silvia, Gelli, Elisa, Martinuzzi, Claudia, Giorgetti, Giulia, Cagnetta, Antonia, Guolo, Fabio, Ivaldi, Federico, Miglino, Maurizio, Aquino, Sara, Todoerti, Katia, Neri, Antonino, Benzi, Andrea, Passalacqua, Mario, Nencioni, Alessio, Perrotta, Ida, Gallo Cantafio, Maria Eugenia, Amodio, Nicola, De Flora, Antonio, Bruzzone, Santina, Lemoli, Roberto M., Cea, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952390/ https://www.ncbi.nlm.nih.gov/pubmed/36830052 http://dx.doi.org/10.3390/antiox12020494 |
Ejemplares similares
-
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023) -
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
por: Soncini, Debora, et al.
Publicado: (2021) -
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
por: Cagnetta, Antonia, et al.
Publicado: (2018) -
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
por: Soncini, Debora, et al.
Publicado: (2019) -
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
por: Becherini, Pamela, et al.
Publicado: (2021)